Trial Information
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
Inclusion Criteria:
- Prostate cancer patient requiring androgen-ablation treatment: LHRH analogs, surgical
castration, antiandrogen treatment
- Provision of informed consent prior to conducting any study-related procedure
Exclusion Criteria:
- Patient involved in a Clinical Trial
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Metabolic syndrome
Outcome Time Frame:
3 months
Safety Issue:
No
Authority:
Spain: Ethics Committee
Study ID:
NIS-OES-DUM-2010/1
NCT ID:
NCT01284608
Start Date:
March 2011
Completion Date:
December 2012
Related Keywords:
- Prostatic Cancer
- Observational
- prospective
- metabolic changes
- metabolic syndrome
- diabetes
- prostatic cancer
- risk fracture
- Prostatic Neoplasms